These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10991857)

  • 1. Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.
    Randegger CC; Keller A; Irla M; Wada A; Hächler H
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2759-63. PubMed ID: 10991857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
    Randegger CC; Hächler H
    J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.
    Jones CH; Ruzin A; Tuckman M; Visalli MA; Petersen PJ; Bradford PA
    Antimicrob Agents Chemother; 2009 Mar; 53(3):977-86. PubMed ID: 19075050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
    Siu LK; Lu PL; Hsueh PR; Lin FM; Chang SC; Luh KT; Ho M; Lee CY
    J Clin Microbiol; 1999 Dec; 37(12):4020-7. PubMed ID: 10565924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.
    Spanu T; Luzzaro F; Perilli M; Amicosante G; Toniolo A; Fadda G;
    Antimicrob Agents Chemother; 2002 Jan; 46(1):196-202. PubMed ID: 11751134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.
    Yagi T; Kurokawa H; Shibata N; Shibayama K; Arakawa Y
    FEMS Microbiol Lett; 2000 Mar; 184(1):53-6. PubMed ID: 10689165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.
    Nüesch-Inderbinen MT; Hächler H; Kayser FH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1726-30. PubMed ID: 7486909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
    Rasheed JK; Jay C; Metchock B; Berkowitz F; Weigel L; Crellin J; Steward C; Hill B; Medeiros AA; Tenover FC
    Antimicrob Agents Chemother; 1997 Mar; 41(3):647-53. PubMed ID: 9056008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHV-16, a beta-lactamase with a pentapeptide duplication in the omega loop.
    Arpin C; Labia R; Andre C; Frigo C; El Harrif Z; Quentin C
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2480-5. PubMed ID: 11502518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
    Jacoby GA; Carreras I
    Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
    Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
    Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.